INTERNATIONAL PATENT: XENON PHARMACEUTICALS INC. FILES APPLICATION FOR "PRODRUGS OF N-[4-(6-FLUORO-3,4-DIHYDRO-2(1 H)-ISOQUINOLINYL)-2,6-DIMETHYLPHE NYL]-3,3-DIMETHYL- BUTANAMIDE"

GENEVA, Jan. 7 -- XENON PHARMACEUTICALS INC. (3650 Gilmore WayBurnaby, BC V5G 4W8) filed a patent application (PCT/US2025/035603) for "PRODRUGS OF N-[4-(6-FLUORO-3,4-DIHYDRO-2(1 H)-ISOQUINOLINYL)-2,6-DIMETHYLPHE NYL]-3,3-DIMETHYL- BUTANAMIDE" on Jun 27, 2025. With publication no. WO/2026/006669, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CLARK, Michael, Philip (c/o Xenon Pharmaceuticals Inc.3650 Gilmore WayBurnaby, BC V5G 4W8), BURFORD, Kristen (c/o Xenon Pharmaceuticals Inc.3650 Gilmore WayBurnaby, BC V5G 4W8), DEHN...